The global healthcare landscape is witnessing a paradigm shift in autoimmune disease management, with Hashimoto thyroiditis emerging as a focal point for pharmaceutical innovation and market development. This prevalent autoimmune condition, affecting millions worldwide through progressive thyroid gland destruction, presents complex therapeutic challenges that extend far...